Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Laymon

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|June 13, 2012
Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomographyLaura E Via, Dan Schimel, Danielle M Weiner, et al.
Molecular Imaging and Biology|July 20, 2019
Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403Xiaoxi Ling, Joseph D Latoche, Cindy J Choy, et al.
The Lancet. Neurology|November 22, 2024
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort studyEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Neuroimage|November 5, 2021
A multi-scanner neuroimaging data harmonization using RAVEL and ComBatMahbaneh Eshaghzadeh Torbati, Davneet S Minhas, Ghasan Ahmad, et al.
Imaging Neuroscience (Cambridge, Mass.)|August 13, 2025
Superpixel-ComBat modeling: A joint approach for harmonization and characterization of inter-scanner variability in T1-weighted imagesChang-Le Chen, Mahbaneh Eshaghzadeh Torbati, Davneet S Minhas, et al.
Neuroimage|January 9, 2021
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Neurobiology of Aging|August 24, 2018
Sleep moderates the relationship between amyloid beta and memory recallKristine A Wilckens, Dana L Tudorascu, Beth E Snitz, et al.
Journal of Neurotrauma|March 19, 2026
Utility of Amyloid Beta and Tau Positron Emission Tomography Scans for Identifying Early-Stage Neurodegenerative Changes in Former Professional Football Players and Healthy Controls: Results from the Brain Health InitiativeShawn R Eagle, Michael Collins, Anthony P Kontos, et al.
Brain Imaging and Behavior|August 5, 2020
Alzheimer's disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging studyKevin J Sullivan, Anran Liu, Chung-Chou H Chang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 25, 2021
Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamenMatthew D Zammit, Charles M Laymon, Dana L Tudorascu, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|June 13, 2012
Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomographyLaura E Via, Dan Schimel, Danielle M Weiner, et al.
Molecular Imaging and Biology|July 20, 2019
Preclinical Dosimetry, Imaging, and Targeted Radionuclide Therapy Studies of Lu-177-Labeled Albumin-Binding, PSMA-Targeted CTT1403Xiaoxi Ling, Joseph D Latoche, Cindy J Choy, et al.
The Lancet. Neurology|November 22, 2024
Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort studyEmily K Schworer, Matthew D Zammit, Jiebiao Wang, et al.
Neuroimage|November 5, 2021
A multi-scanner neuroimaging data harmonization using RAVEL and ComBatMahbaneh Eshaghzadeh Torbati, Davneet S Minhas, Ghasan Ahmad, et al.
Imaging Neuroscience (Cambridge, Mass.)|August 13, 2025
Superpixel-ComBat modeling: A joint approach for harmonization and characterization of inter-scanner variability in T1-weighted imagesChang-Le Chen, Mahbaneh Eshaghzadeh Torbati, Davneet S Minhas, et al.
Neuroimage|January 9, 2021
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndromeMatthew D Zammit, Dana L Tudorascu, Charles M Laymon, et al.
Neurobiology of Aging|August 24, 2018
Sleep moderates the relationship between amyloid beta and memory recallKristine A Wilckens, Dana L Tudorascu, Beth E Snitz, et al.
Journal of Neurotrauma|March 19, 2026
Utility of Amyloid Beta and Tau Positron Emission Tomography Scans for Identifying Early-Stage Neurodegenerative Changes in Former Professional Football Players and Healthy Controls: Results from the Brain Health InitiativeShawn R Eagle, Michael Collins, Anthony P Kontos, et al.
Brain Imaging and Behavior|August 5, 2020
Alzheimer's disease pathology in a community-based sample of older adults without dementia: The MYHAT neuroimaging studyKevin J Sullivan, Anran Liu, Chung-Chou H Chang, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 25, 2021
Patterns of glucose hypometabolism in Down syndrome resemble sporadic Alzheimer's disease except for the putamenMatthew D Zammit, Charles M Laymon, Dana L Tudorascu, et al.
Pageof 9